Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/7329| Title: | Risk of cancer in Turkish patients after treatment with TNF antagonists | Authors: | Pay, S. Öztürk, M.A. Can, G. Cefle, A. Çobankara, Veli. Erer, B. Gö?üş, F. |
Keywords: | adalimumab etanercept infliximab antirheumatic agent tumor necrosis factor alpha adult ankylosing spondylitis cancer risk drug substitution drug withdrawal female health survey hematologic malignancy human juvenile rheumatoid arthritis letter major clinical study male priority journal psoriatic arthritis rheumatoid arthritis risk assessment risk factor solid tumor Turkey (republic) adolescent arthritis chemically induced disorder clinical trial drug antagonism middle aged multicenter study neoplasm Adolescent Adult Antirheumatic Agents Arthritis Female Humans Male Middle Aged Neoplasms Risk Assessment Tumor Necrosis Factor-alpha |
Publisher: | Oxford University Press | Abstract: | Abstract Not Available | URI: | https://hdl.handle.net/11499/7329 https://doi.org/10.1093/rheumatology/ken026 |
ISSN: | 1462-0324 |
| Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| ken026.pdf | 128.52 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
8
checked on Nov 16, 2024
Page view(s)
24
checked on Aug 24, 2024
Download(s)
28
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.